SMS Pharmaceuticals Limited
NSE:SMSPHARMA.NS
355.2 (INR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 7,092.634 | 5,220.514 | 5,150.158 | 5,608.173 | 4,073.453 | 4,618.235 | 4,605.146 | 6,537.325 | 6,031.934 | 5,792.858 | 5,180.38 | 2,423.266 | 2,140.974 | 2,242.743 | 2,197.551 | 2,447.867 | 2,104.067 | 1,731.441 | 1,290.32 | 1,186.526 |
Cost of Revenue
| 5,933.733 | 3,931.316 | 3,335.86 | 3,793.921 | 2,799.997 | 3,275.503 | 3,244.032 | 4,159.187 | 3,898.139 | 3,854.782 | 3,675.715 | 1,993.959 | 1,405.827 | 1,556.128 | 1,692.101 | 1,918.768 | 1,478.654 | 1,118.539 | 872.832 | 832.999 |
Gross Profit
| 1,158.901 | 1,289.198 | 1,814.298 | 1,814.252 | 1,273.456 | 1,342.732 | 1,361.114 | 2,378.138 | 2,133.795 | 1,938.076 | 1,504.665 | 429.307 | 735.147 | 686.614 | 505.45 | 529.1 | 625.414 | 612.902 | 417.488 | 353.526 |
Gross Profit Ratio
| 0.163 | 0.247 | 0.352 | 0.324 | 0.313 | 0.291 | 0.296 | 0.364 | 0.354 | 0.335 | 0.29 | 0.177 | 0.343 | 0.306 | 0.23 | 0.216 | 0.297 | 0.354 | 0.324 | 0.298 |
Reseach & Development Expenses
| 0 | 89.192 | 83.934 | 73.484 | 74.385 | 70.437 | 51.434 | 40.217 | 34.793 | 22.958 | 14.027 | 82.375 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 55.874 | 49.476 | 41.061 | 27.983 | 22.542 | 25.534 | 30.256 | 48.842 | 76.336 | 60.517 | 44.206 | 87.612 | 34.598 | 32.622 | 27.285 | 30.919 | 21.843 | 34.843 | 33.703 |
Selling & Marketing Expenses
| 0 | 38.231 | 34.209 | 50.903 | 36.993 | 22.499 | 33.353 | 84.731 | 44.566 | 92.457 | 101.228 | 33.705 | 61.063 | 65.363 | 63.409 | 57.767 | 48.097 | 90.564 | 71.452 | 62.281 |
SG&A
| 307.862 | 94.105 | 83.685 | 91.964 | 64.976 | 45.041 | 58.887 | 114.987 | 93.408 | 532.736 | 455.435 | 77.911 | 148.675 | 99.961 | 96.031 | 85.052 | 79.016 | 112.407 | 106.295 | 95.984 |
Other Expenses
| 44.597 | 48.856 | 20.586 | 25.68 | 29.657 | 20.81 | 12.85 | 9.767 | 1,327.096 | 1,247.132 | 1,061.537 | 747.585 | 334.913 | 231.811 | 168.976 | -24.904 | 88.419 | 64.747 | 86.691 | 71.192 |
Operating Expenses
| 307.862 | 1,065.413 | 989.608 | 825.617 | 693.366 | 633.997 | 626.359 | 1,593.268 | 1,420.504 | 1,247.132 | 1,061.537 | 825.496 | 483.588 | 331.772 | 265.007 | 253.205 | 167.434 | 177.154 | 192.986 | 167.175 |
Operating Income
| 851.039 | 272.641 | 821.768 | 988.635 | 580.09 | 708.735 | 734.755 | 784.87 | 713.291 | 690.944 | 443.128 | -396.189 | 251.559 | 354.843 | 240.444 | 275.895 | 457.979 | 435.748 | 224.502 | 186.351 |
Operating Income Ratio
| 0.12 | 0.052 | 0.16 | 0.176 | 0.142 | 0.153 | 0.16 | 0.12 | 0.118 | 0.119 | 0.086 | -0.163 | 0.117 | 0.158 | 0.109 | 0.113 | 0.218 | 0.252 | 0.174 | 0.157 |
Total Other Income Expenses Net
| -189.971 | -219.15 | -136.777 | -77.437 | -72.534 | -85.192 | -131.273 | -187.957 | -150.567 | -16.109 | -122.947 | 692.829 | -237.384 | -250.006 | -211.635 | -196.438 | -134.252 | -109.038 | -93.527 | -68.615 |
Income Before Tax
| 661.068 | 53.491 | 684.991 | 911.198 | 507.556 | 623.543 | 603.482 | 596.913 | 562.724 | 674.835 | 320.181 | 296.64 | 14.175 | 104.837 | 28.809 | 79.457 | 323.727 | 326.71 | 130.975 | 117.735 |
Income Before Tax Ratio
| 0.093 | 0.01 | 0.133 | 0.162 | 0.125 | 0.135 | 0.131 | 0.091 | 0.093 | 0.116 | 0.062 | 0.122 | 0.007 | 0.047 | 0.013 | 0.032 | 0.154 | 0.189 | 0.102 | 0.099 |
Income Tax Expense
| 169.068 | 14.65 | 6.182 | 301.552 | 180.671 | 209.008 | 198.939 | 115.197 | 146.332 | 322.39 | 116.336 | 43.391 | 2.8 | 20.91 | 4.855 | 16.472 | 52.121 | 117.026 | 45.899 | 33.272 |
Net Income
| 498.26 | -70.593 | 622.199 | 625.269 | 315.737 | 400.484 | 317.497 | 410.398 | 408.921 | 352.445 | 203.845 | 253.249 | 11.375 | 83.927 | 23.954 | 62.985 | 271.606 | 209.684 | 85.076 | 84.463 |
Net Income Ratio
| 0.07 | -0.014 | 0.121 | 0.111 | 0.078 | 0.087 | 0.069 | 0.063 | 0.068 | 0.061 | 0.039 | 0.105 | 0.005 | 0.037 | 0.011 | 0.026 | 0.129 | 0.121 | 0.066 | 0.071 |
EPS
| 5.89 | -0.83 | 7.35 | 7.39 | 3.73 | 4.73 | 3.75 | 3.37 | 4.83 | 4.16 | 2.31 | 2.53 | 0.11 | 0.84 | 0.24 | 0.63 | 2.72 | 2.95 | 2.08 | 2.06 |
EPS Diluted
| 5.89 | -0.83 | 7.35 | 7.39 | 3.73 | 4.73 | 3.75 | 3.37 | 4.83 | 4.16 | 2.31 | 2.53 | 0.11 | 0.84 | 0.24 | 0.63 | 2.72 | 2.95 | 2.08 | 2.06 |
EBITDA
| 1,166.196 | 593.895 | 1,188.119 | 1,236.63 | 840.664 | 930.48 | 950.519 | 1,047.823 | 917.886 | 1,009.043 | 571.674 | -500.626 | 383.151 | 555.127 | 400.142 | 414.316 | 575.373 | 515.157 | 295.635 | 245.289 |
EBITDA Ratio
| 0.164 | 0.114 | 0.231 | 0.221 | 0.206 | 0.201 | 0.206 | 0.16 | 0.152 | 0.174 | 0.11 | -0.207 | 0.179 | 0.248 | 0.182 | 0.169 | 0.273 | 0.298 | 0.229 | 0.207 |